共 50 条
Chitosan and its derivatives as nanocarriers for siRNA delivery
被引:14
|作者:
Al-Qadi, S.
[1
]
Grenha, A.
[2
]
Remunan-Lopez, C.
[1
]
机构:
[1] Univ Santiago de Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Nanobiofar Grp, Santiago De Compostela 15782, Spain
[2] Univ Algarve, IBB Inst Biotechnol & Bioengn, CBME Ctr Mol & Struct Biomed, Faro, Portugal
关键词:
Chitosan;
Chitosan derivatives;
Formulation parameters;
Gene silencing;
Nanocarriers;
siRNA delivery;
SMALL INTERFERING RNA;
TARGETED GENE DELIVERY;
NUCLEIC-ACID DELIVERY;
MOLECULAR-WEIGHT;
IN-VITRO;
DRUG-DELIVERY;
ANTISENSE OLIGONUCLEOTIDES;
ANTIINFLAMMATORY TREATMENT;
NANOPARTICLE FORMULATION;
INTRAVENOUS DELIVERY;
D O I:
10.1016/S1773-2247(12)50003-1
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The ability to specifically silence genes using siRNA has enormous potential for treating genetic diseases. However, siRNA instability and biodistribution issues still need to be overcome, and adequate delivery vehicles have proven indispensable in conveying siRNA to its target. Chitosan is a promising biopolymer for siRNA delivery, its interest stemming from its solely, biodegradability, mucoadhesivity, permeation enhancing effect and cationic charge, as well as amenability to undergo chemical modifications. Chitosan and its derivatives can be readily arranged into complexes or nanoparticles able to entrap and carry siRNA. Specific strategies have been adopted to improve chitosan-based vectors with regard to transfectability. However, further efforts cure required to verify their value and adapt them to enhance therapeutic output prior to clinical application. This review emphasizes the potential of chitosan and its derivatives to develop nanocarriers for siRNA delivery. The properties of chitosan that are significant for transfectability and the most relevant findings are assessed.
引用
收藏
页码:29 / 42
页数:14
相关论文